You are here

  • Home
  • Archive
  • Volume 6, Issue Suppl 1
  • 209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension

Article metrics

Article menu

Download PDFPDF

Abstracts
209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension
Free

 

Online download statistics by month:

Online download statistics by month: April 2019 to September 2024

AbstractFullPdf
Apr 201930013
May 20191605
Jun 20191704
Jul 20192003
Aug 2019901
Sep 20191001
Oct 20191307
Nov 20193605
Dec 20192002
Jan 20206501
Feb 20205703
Mar 20205401
Apr 20205702
May 20206003
Jun 20205802
Jul 20206901
Aug 20204900
Sep 20208201
Oct 20208308
Nov 20205802
Dec 20206603
Jan 20214901
Feb 2021602
Mar 2021601
Apr 2021802
May 2021403
Jun 2021001
Jul 2021003
Aug 2021006
Sep 2021105
Oct 202112014
Nov 20218015
Dec 20211602
Jan 2022604
Feb 2022800
Mar 20221601
Apr 2022901
May 2022804
Jun 20221202
Jul 20221903
Aug 20222405
Sep 20221805
Oct 2022803
Nov 20221604
Dec 2022300
Jan 2023605
Feb 2023400
Mar 20231000
Apr 2023203
May 2023200
Jun 2023002
Jul 20231004
Aug 2023701
Sep 2023200
Oct 2023600
Nov 2023603
Dec 2023401
Jan 20241000
Feb 20241000
Mar 202413013
Apr 2024604
May 2024806
Jun 20241401
Jul 20241306
Aug 20241502
Sep 20241602
Total13500208